Med. 2021 ,27, 515–525. [CrossRef] [PubMed] 127. Honda, M.; Asai, T.; Oku, N.; Araki, Y.; Tanaka, M.; Ebihara, N. Liposomes and Nanotechnology in Drug Development: Focus on Ocular Targets. Int. J. Nanomed. 2013 ,8, 495–503. [CrossRef] 128. Mi, Y.; Hagan, C.T., 4th; Vincent, B.G.; Wang, A.Z. Emerging Nano-/Microapproaches for Cancer Immunotherapy. Adv. Sci. 2019 , 6, 1801847. [CrossRef] 129. Melief, C.J.M.; van der Burg, S.H. Immunotherapy of Established (Pre)Malignant Disease by Synthetic Long Peptide Vaccines. Nat. Rev. Cancer 2008 ,8, 351–360. [CrossRef] 130. Kuai, R.; Ochyl, L.J.; Bahjat, K.S.; Schwendeman, A.; Moon, J.J. Designer Vaccine Nanodiscs for Personalized Cancer Immunother- apy. Nat.